Hint mode is switched on Switch off

Castle Biosciences, ordinary share
CSTL, US14843C1053

Add a stock to WL
Choose all Reset all
Castle Biosciences, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Castle Biosciences is a commercial-stage dermatological cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions.
  • Issuer
  • Full borrower / issuer name
    Castle Biosciences, Inc.
  • Industry
    Medical Services

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CSTL
  • Placement
    25.07.2019
  • Lock up period
    180
  • Number of papers
    4,000,000
  • Volume of raised funds
    64 mln USD
  • Placement share
    24.92%
  • Final placement price
    16 USD
  • Price change since placement date
    27.44%
  • By capitalization
    256.78 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CSTL
  • Placement
    25.06.2020
  • Lock up period
    180
  • Number of papers
    2,000,000
  • Volume of raised funds
    74 mln USD
  • Placement share
    10.41%
  • Final placement price
    37 USD
  • Price change since placement date
    -44.89%
  • By capitalization
    710.53 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CSTL
  • Placement
    16.12.2020
  • Lock up period
    180
  • Number of papers
    4,000,000
  • Volume of raised funds
    232 mln USD
  • Placement share
    16.78%
  • Final placement price
    58 USD
  • Price change since placement date
    -64.84%
  • By capitalization
    1,382.98 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
II q eng
III q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

11/01/2026 Castle Biosciences: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
22/12/2025 Castle Biosciences, Inc. (NASDAQ: CSTL) Price Target and Insider Selling Insight
05/08/2025 Castle Biosciences: Financial Statements And Exhibits
01/08/2025 Castle Biosciences, Inc. (NASDAQ:CSTL) Earnings Preview: A Mixed Financial Outlook
22/05/2025 Castle Biosciences: Material Modifications Of Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.